PROGRESSIVE MULTIPLE SCLEROSIS (PMS)
Clinical trials for PROGRESSIVE MULTIPLE SCLEROSIS (PMS) explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE MULTIPLE SCLEROSIS (PMS) trials appear
Sign up with your email to follow new studies for PROGRESSIVE MULTIPLE SCLEROSIS (PMS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for progressive MS: ocrelizumab trial targets disability
Disease control OngoingThis study is testing the drug ocrelizumab in 927 people with progressive multiple sclerosis (MS), a form of the disease that steadily worsens. Participants receive infusions every 24 weeks for about 4 years. The main goal is to see if the drug can stop or slow disability progres…
Matched conditions: PROGRESSIVE MULTIPLE SCLEROSIS (PMS)
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
MS trial withdrawn before it began: CAR T-Cell hope on hold
Disease control TerminatedThis study aimed to test a new treatment called CABA-201, a CAR T-cell therapy made from a patient's own immune cells, for people with multiple sclerosis (MS). The goal was to see if it was safe and could control the disease by targeting and resetting the immune system. However, …
Matched conditions: PROGRESSIVE MULTIPLE SCLEROSIS (PMS)
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC